CEO of Insmed (makers of Iplex) Resigns

The CEO of Insmed, the pharmaceutical company that produces ALS treatment option IPLEX, has stepped down from his position citing health concerns.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail